Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | FNTA | P49354 | 1/20 | 0.49 |
| ▸ | FNTB | P49356 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 4/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 3/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5861604 | 1.00 | HTT (0.53) | HTTALDH1A1FNTAFNTBPOLB | |
| SCHEMBL5392384 | 0.84 | LMNA (0.46) | HTTALDH1A1POLBKDM4EMEN1 | |
| SCHEMBL2704334 | 0.81 | TSHR (0.53) | HTTALDH1A1POLBMEN1KMT2A | |
| SCHEMBL22868105 | 0.81 | CA12 (0.46) | ALDH1A1FNTAFNTBPOLBMEN1 | |
| SCHEMBL30797201 | 0.81 | ACACB (0.45) | ALDH1A1POLBKDM4EMEN1KMT2A | |
| SCHEMBL5861572 | 0.80 | ALDH1A1 (0.50) | ALDH1A1KDM4EMEN1KMT2AMAPT | |
| SCHEMBL2705958 | 0.80 | ALDH1A1 (0.50) | ALDH1A1KDM4EMEN1KMT2AMAPT | |
| SCHEMBL4124188 | 0.80 | ALDH1A1 (0.50) | ALDH1A1KDM4EMEN1KMT2AMAPT | |
| SCHEMBL11711515 | 0.80 | SMN1; SMN2 (0.52) | ALDH1A1POLBKDM4EMEN1KMT2A | |
| SCHEMBL2703752 | 0.79 | CA12 (0.44) | ALDH1A1FNTAFNTBPOLBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7145030-B2 | Production method for optically active N-aryl-β-amino acid compounds | AJINOMOTO CO., INC. (JP) | 2006-12-05 | — | — | US | disclosed |
| US-20040267043-A1 | Production method for optically active N-aryl-beta-amino acid compounds | AJINOMOTO CO., INC. (JP) | 2004-12-30 | — | — | US | disclosed |
| EP-1471050-A1 | Production method for optically active N-aryl-beta-amino acid compounds | Ajinomoto Co., Inc. (JP) | 2004-10-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040267043-A1 | Production method for optically active N-aryl-beta-amino acid compounds | AADAT, AADAC, DDC | HTT 87/4885ALDH1A1 588/4885FNTA 473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.